Volume 37, Issue 3, March 2022

Do we have to rely on metric-based quality improvement strategies for the management of ESKD?

• Extract
• View article

Disparities in decision-making practices for dialysis modality in advanced chronic kidney disease: closing the gap across Europe

• Extract
• View article

Haemoglobin as a marker of fibrosis in early diabetic kidney disease

• Extract
• View article

Beyond exercise: supporting a range of physical activity for people receiving dialysis

• Extract
• View article

Spironolactone and chlorthalidone—old drugs, new uses—but approach with caution

• Extract
• View article

Haematological disorders following kidney transplantation

• Abstract
• View article

Magnesium to prevent kidney disease–associated vascular calcification: crystal clear?

• Abstract
• View article

Assessment of pre-donation glomerular filtration rate: going back to basics

• Abstract
• View article

Artificial intelligence: is there a potential role in nephropathology?

• Extract
• View article

Contrast and acute kidney injury: what is left to enhance?

• Extract
• View article

Osteocrin, a bone-derived humoral factor, exerts a renoprotective role in ischemia–reperfusion injury in mice

• Abstract
• View article
• Supplementary data

Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia–reperfusion injury

• Abstract
• View article
• Supplementary data

Prolonged patient survival after implementation of a continuous quality improvement programme empowered by digital transformation in a large dialysis network

• Abstract
• View article
• Supplementary data

Patient-reported factors influencing the choice of their kidney replacement treatment modality

• Abstract
• View article
• Supplementary data

Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study

• Abstracts
• View article
• Supplementary data

Circulating angiopoietin-2 and angiogenic microRNAs associate with cerebral small vessel disease and cognitive decline in older patients reaching end-stage renal disease

• Abstract
• View article
• Supplementary data

Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib

• Abstract
• View article
• Supplementary data

Energy expenditure estimates in chronic kidney disease using a novel physical activity questionnaire

• Abstract
• View article
• Supplementary data

Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia

• Abstract
• View article
• Supplementary data

Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review

• Abstract
• View article
• Supplementary data

Using datasets to ascertain the generalizability of clinical cohorts: the example of the European QUALity study on the treatment of advanced chronic kidney disease

• Abstract
• View article
• Supplementary data

Dietary sodium intake does not alter renal potassium handling and blood pressure in healthy young males

• Abstract
• View article
• Supplementary data

Addressing feasibility challenges to delivering intradialytic exercise interventions: a theory-informed qualitative study

• Abstract
• View article
• Supplementary data

Asystole episodes and bradycardia in patients with end-stage renal disease

• Abstracts
• View article

Impact of obesity in kidney transplantation: a prospective cohort study from French registries between 2008 and 2014

• Abstracts
• View article
• Supplementary data

Country-specific sex disparities in living kidney donation

• Extract
• View article

Bartonellosis mimicking post-transplant lymphoproliferative diseases

• Extract
• View article
• Supplementary data

Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients

• Extract
• View article
• Supplementary data